Metabolic switch in lung cancer reprograms immune cells to slow tumors

An international research team, led by Justus Liebig University Giessen (JLU), the Institute for Lung Health (ILH) in Giessen, and the Max Planck Institute for Heart and Lung Research in Bad Nauheim, has identified a promising mechanism for combating lung cancer.

The researchers discovered that a specific endogenous metabolic process can induce the immune system to directly attack tumor cells and stop their growth.

This opens new avenues for targeted therapies.

The results have been published in the journal Cell Metabolism. ...